State of the Art: Concise ReviewStereotactic Ablative Radiation Therapy for the Treatment of Early-stage Non–Small-Cell Lung Cancer: CEPO Review and Recommendations
Key Words
Cited by (0)
Disclosure: The authors declare no conflict of interest.
The INESSS provided financial support for the present work.
This article is an adaptation of the CEPO’s original clinical practice guideline published in June 2014, which is freely available in French at www.inesss.qc.ca. The INESSS and the Direction québécoise de cancérologie of the Ministère de la Santé et des Services sociaux du Québec provided financial support for the original guideline.
- **
The Comité de l’évolution des pratiques en oncologie (CEPO), a group of specialists in oncology that reports to the INESSS. Its role is to provide physicians and other health professionals in the field of oncology with evidence-based guidelines and clinical support tools to optimize and standardize clinical practice in the province of Québec, Canada. The CEPO’s members are Karine Almanric, BPharm, MSc, BCOP, Hôpital de la Cité-de-la-Santé (CSSS de Laval); Jean-Sébastien Aucoin, MD, Centre hospitalier affilié universitaire régional (CSSS de Trois-Rivières); Gino Boily, PhD, INESSS; Philippe Bouchard BPharm, MSc, BCOP, Hôpital Maisonneuve-Rosemont; Jim Boulanger, PhD, INESSS; Alexis Bujold, MD, Hôpital Maisonneuve-Rosemont; Ghislain Cournoyer, MD, Hôpital régional de Saint-Jérôme (CSSS de Saint-Jérôme); Félix Couture, MD, Hôtel-Dieu de Québec (CHU de Québec); Normand Gervais, MD, Centre hospitalier régional du Grand-Portage (CSSS de Rivière-du-Loup); Stéphanie Goulet, PhD, INESSS; Marie-Pascale Guay, BPharm, MSc, BCOP, Jewish General Hospital (MUHC); Bernard Lespérance, MD, Hôpital du Sacré-Cœur de Montréal, Groupe d’étude en oncologie du Québec; Nathalie Letarte, BPharm, MSc, BCOP, Hôpital Notre-Dame (CHUM), Programme de gestion thérapeutique des médicaments; Jean-François Ouellet, MD, Hôtel-Dieu de Québec (CHU de Québec); Gilles Pineau, MD, INESSS; Raghu Rajan, MD, Montreal General Hospital (MUHC); Isabelle Roy, MD, Hôpital de la Cité-de-la-Santé (CSSS de Laval); Benoît Samson, MD, Hôpital Charles-LeMoyne (CSSS Champlain-Charles-LeMoyne); and François Vincent, MD, Centre hospitalier affilié universitaire régional (CSSS de Trois-Rivières)